Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

The firm saw an improvement in progression-free survival for patients on the ivonescimab regimen and a trend toward improved overall survival.

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

This story contains details from testimony referencing suicide and suicidal ideations that are graphic, and some readers may ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...

Capricor Therapeutics is seeking FDA approval for CAP-1002, targeting heart function in Duchenne Muscular Dystrophy patients.

Results of a randomized, placebo-controlled study demonstrated avatrombopag achieved the primary endpoint of platelet response in heavily pretreated pediatric patients with persistent or chronic ITP.

Every drug, vaccine and diagnostic test we take has to undergo rigorous clinical testing for safety, quality and ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, chemotherapy or radiation, the study found.

Researchers hope to launch human clinical ... trials in their quest for a vaccine to prevent the buildup of pathological tau -- a protein in the brain associated with Alzheimer's dementia. In a ...